Copyright © 2014 University of York.
Bookshelf ID: NBK184852
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
Show detailsBibliographic details: Mukai T, Kishi T, Matsuda Y, Iwata N. A meta-analysis of inositol for depression and anxiety disorders. Human Psychopharmacology 2014; 29(1): 55-63. [PubMed: 24424706]
Abstract
OBJECTIVE: This study is a meta-analysis of inositol as a treatment for depression and anxiety disorders.
METHODS: PubMed, Cochrane Library database, and PsycINFO were searched up to 14 August 2013. A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials (RCTs) were conducted comparing inositol for depressed or anxiety disorder patients.
RESULTS: Seven RCTs in depression (two bipolar depression studies, one bipolar depression and major depressive disorder (MDD) study, two MDD studies, and two premenstrual dysphoric disorder (PMDD) studies) (n = 242) were identified. Four RCTs in anxiety disorders (two obsessive-compulsive disorder studies, one panic disorder study, and one posttraumatic stress disorder study) (n = 70) were also identified. There were no statistically significant effects of inositol on depressive, anxiety, and obsessive-compulsive symptoms and discontinuation (all-cause, side effects, and worsening psychiatric symptoms). However, inositol had marginally more responders in depression than placebo (p = 0.06), and inositol showed a trend towards superior efficacy for depressive symptoms in patients with PMDD (p = 0.07). Inositol marginally caused gastrointestinal upset compared with placebo (p = 0.06).
CONCLUSIONS: Our results suggest that inositol may be beneficial for depressed patients, especially those with PMDD. The main limitation of this report is that a small number of studies were included in this meta-analysis.
Copyright © 2013 John Wiley & Sons, Ltd.
- Pharmacotherapy for anxiety and comorbid alcohol use disorders.[Cochrane Database Syst Rev. 2015]Pharmacotherapy for anxiety and comorbid alcohol use disorders.Ipser JC, Wilson D, Akindipe TO, Sager C, Stein DJ. Cochrane Database Syst Rev. 2015 Jan 20; 1(1):CD007505. Epub 2015 Jan 20.
- Omega-3 fatty acids for depression in adults.[Cochrane Database Syst Rev. 2015]Omega-3 fatty acids for depression in adults.Appleton KM, Sallis HM, Perry R, Ness AR, Churchill R. Cochrane Database Syst Rev. 2015 Nov 5; 2015(11):CD004692. Epub 2015 Nov 5.
- Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.[Cochrane Database Syst Rev. 2015]Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.McCloud TL, Caddy C, Jochim J, Rendell JM, Diamond PR, Shuttleworth C, Brett D, Amit BH, McShane R, Hamadi L, et al. Cochrane Database Syst Rev. 2015 Sep 29; (9):CD011611. Epub 2015 Sep 29.
- Antidepressants for the treatment of depression in people with cancer.[Cochrane Database Syst Rev. 2018]Antidepressants for the treatment of depression in people with cancer.Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M. Cochrane Database Syst Rev. 2018 Apr 23; 4(4):CD011006. Epub 2018 Apr 23.
- Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.[Cochrane Database Syst Rev. 2015]Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.Olthuis JV, Watt MC, Bailey K, Hayden JA, Stewart SH. Cochrane Database Syst Rev. 2015 Mar 5; (3):CD011565. Epub 2015 Mar 5.
- A meta-analysis of inositol for depression and anxiety disorders - Database of A...A meta-analysis of inositol for depression and anxiety disorders - Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews
Your browsing activity is empty.
Activity recording is turned off.
See more...